Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ACLY | P53396 | 1/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17520315 | 1.00 | TSHR (0.48) | TSHRMAPTABCC4ALDH1A1LMNA | |
| SCHEMBL7606780 | 1.00 | TSHR (0.48) | TSHRMAPTABCC4ALDH1A1LMNA | |
| SCHEMBL18480166 | 1.00 | TSHR (0.48) | TSHRMAPTABCC4ALDH1A1LMNA | |
| SCHEMBL3121245 | 1.00 | TSHR (0.48) | TSHRMAPTABCC4ALDH1A1LMNA | |
| SCHEMBL22366994 | 0.98 | TSHR (0.44) | TSHRMAPTABCC4ALDH1A1LMNA | |
| SCHEMBL4646715 | 0.90 | — | — | |
| SCHEMBL28891166 | 0.82 | TSHR (0.44) | TSHRMAPTABCC4ALDH1A1LMNA | |
| SCHEMBL16302651 | 0.82 | TSHR (0.44) | TSHRMAPTABCC4ALDH1A1LMNA | |
| SCHEMBL22368446 | 0.81 | TSHR (0.36) | TSHRMAPTABCC4ALDH1A1LMNA | |
| SCHEMBL14088846 | 0.81 | TSHR (0.36) | TSHRMAPTABCC4ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170247314-A1 | FRAGRANCES FROM THE ESTERS OF FATTY ACIDS | P2 SCIENCE, INC. | 2017-08-31 | — | — | US | disclosed |
| US-20170247314-A1 | FRAGRANCES FROM THE ESTERS OF FATTY ACIDS | P2 SCIENCE, INC. | 2017-08-31 | — | — | US | disclosed |
| WO-2017139637-A1 | FRAGRANCE COMPOSITIONS COMPRISING COMPOUNDS WITH OLFACTORY QUALITIES | P2 SCIENCE, INC. (US) | 2017-08-17 | — | — | WO | disclosed |
| WO-2016022803-A2 | FRAGRANCES FROM THE ESTERS OF FATTY ACIDS | P2 SCIENCE, INC. (US) | 2016-02-11 | — | — | WO | disclosed |
| US-4002179-A | Smoking compositions incorporating a menthol-release agent | PHILIP MORRIS INCORPORATED (US) | 1977-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170247314-A1 | FRAGRANCES FROM THE ESTERS OF FATTY ACIDS | ELOVL5, FASN, ELOVL1 | TSHR 4078/4885MAPT 2179/4885ABCC4 2021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.